Allopurinol, an inhibitor of XO commonly used as a urate-lowering therapy for gout, has been shown to reduce oxidative stress and improve endothelial dysfunction in patients with CVD, diabetes, and hypertension [30]. Here, XDH is linked to endothelial dysfunction.